Revvity Inc (RVTY)
111.99
-0.51
(-0.45%)
USD |
NYSE |
Dec 27, 16:00
112.01
+0.02
(+0.02%)
After-Hours: 20:00
Revvity Research and Development Expense (Quarterly): 49.14M for Sept. 30, 2024
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
Bionano Genomics Inc | 4.717M |
Bruker Corp | 98.10M |
Azenta Inc | 8.412M |
Harvard Bioscience Inc | 2.567M |
Akoya Biosciences Inc | 4.474M |